P53 was expressed in more than 25% of the tumor cells in 46 patients (30.5%); C-erbB2 was 3+ in 30 patients (19.9%); and Ki-67 was 5% or more in 56 patients (37.1%). The gene discussed is TP53; the disease is neoplasm.